BASSAGANYA-RIERA JOSEP (Chairman, President and CEO) sold 0.7% of their position (50.43K shares) of LANDOS BIOPHARMA, INC. on the open market
Open‑market sale worth $364.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/1/2021ACC: 0001843575-21-000005
DirectorOfficer10% Owner· Chairman, President and CEO
Since Feb 2021
-50.43K
Net shares
Net seller
$364.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50.43K disposed
Non-Derivative Transactions2
common stock
Indirect
Shares
−15.43K
Price / share
$7.58
Trade value
$116.88K
% of position
0.2%
11/29/2021
7.44M→7.43M
common stock
Indirect
Shares
−35K
Price / share
$7.06
Trade value
$247.17K
% of position
0.5%
11/30/2021
7.43M→7.39M
Total
Net shares
−50.43K
Net value
-$364.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Indirect | 11/29/2021 | S · Sale | −15.43K | $7.58 | $116.88K | 0.2% | 7.44M | 7.43M |
| common stock Indirect | 11/30/2021 | S · Sale | −35K | $7.06 | $247.17K | 0.5% | 7.43M | 7.39M |
| Total | −50.43K | -$364.05K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
common stock
IndirectShares owned766.40K
common stock
IndirectShares owned823.96K
common stock
IndirectShares owned786.30K
Total
2.38M indirect2.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| common stock | 766.40K | Indirect |
| common stock | 823.96K | Indirect |
| common stock | 786.30K | Indirect |
| Total | 2.38M | 2.38M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported